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Résumé en
anglais
Lipid nanocapsules (LNCs) are a new generation of biomimetic nanocarriers obtained
via a phase inversion temperature method and have an oily core of medium-chain
triglycerides that is surrounded by a shelf containing a lipophilic surfactant (lecithin)
and a hydrophilic surfactant macrogol 15-hydroxystearate. The aim of the present
study was to produce LNCs with antibacterial activity by replacing lecithin with other
lipophilic surface active compounds, namely medium-chain fatty acids and their 1-
monoglycerides, which are known to have antimicrobial properties. Fatty acids and
monoglycerides were found to affect the properties of LNCs, such as particle size and
zeta potential. Incorporation of a co-surfactant decreased significantly particle size
(p⩽0.0039). Furthermore, incorporation of either lecithin or fatty acids with at least
10 carbon atoms yielded LNCs with the zeta potential significantly more negative
than that of LNCs composed solely of triglycerides and macrogol 15 hydroxystearate
(p⩽0.0310). Moreover, they were capable of decreasing the phase inversion
temperature. The activity of the LCNs against Gram-positive S. aureus, including a
methicillin-resistant strain, increased with increases in the length of the hydrocarbon
tail. Monoglyceride-LNCs were found to be more active than the corresponding fatty
acids. The opposite behaviour was observed for Gram-negative bacteria, whereby
only caproic acid- and caprylic acid-LNCs were found to be active against these
organisms. The monoglyceride-LNCs were bactericidal, and they killed in a time-
dependent manner. Fatty acid-LNCs killed in a concentration-dependent manner. A
haemolysis assay was performed to obtain preliminary information on the safety of
the tested LNCs. In the case of fatty acid-LNCs, the concentrations at which bacterial
growth was inhibited were similar to the haemolytic concentrations. However,
monoglyceride-LNCs showed antibacterial action at concentrations much lower than
those at which haemolysis was observed. In conclusion, monoglyceride-LNCs are
promising candidates as carriers for the encapsulation of antibacterial agents,
particularly against S. aureus.
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